The heart undergoes profound morphological and functional changes as it continues to mature postnatally. However, this phase of cardiac development remains understudied. More recently, cardiac maturation research has attracted a lot of interest due to the need for more mature stem cell-derived cardiomyocytes for disease modeling, drug screening and heart regeneration. Additionally, neonatal heart injury models have been utilized to study heart regeneration, and factors regulating postnatal heart development have been associated with adult cardiac disease. Critical components of cardiac maturation are systemic and local biochemical cues. Specifically, cardiac innervation and the concentration of various metabolic hormones appear to increase perinatally and they have striking effects on cardiomyocytes. Here, we first report some of the key parameters of mature cardiomyocytes and then discuss the specific effects of neurons and hormonal cues on cardiomyocyte maturation. We focus primarily on the structural, electrophysiologic, metabolic, hypertrophic and hyperplastic effects of each factor. This review highlights the significance of underappreciated regulators of cardiac maturation and underscores the need for further research in this exciting field.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434956 | PMC |
| http://dx.doi.org/10.1016/j.semcdb.2021.03.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unearthing the Unexpected: First Report of Ossa Cordis in a Human Heart.
Am J Forensic Med Pathol
January 2025
From the Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC.
The ossa cordis (OC), or cardiac bone, is a bony structure within the cardiac skeleton of mammals, believed to maintain heart shape during systole and enhance contraction efficiency. Found in large mammals, especially ruminants, and has recently been described in chimpanzees; however, OC has not previously been described in humans. Herein, we present an incidental finding of OC in the heart of a 39-year-old man who suffered a stab wound to chest.
View Article and Find Full Text PDFmorphoHeart: A quantitative tool for integrated 3D morphometric analyses of heart and ECM during embryonic development.
PLoS Biol
January 2025
School of Biosciences and Bateson Centre, University of Sheffield, Western Bank, Sheffield, United Kingdom.
Heart development involves the complex structural remodelling of a linear heart tube into an asymmetrically looped and ballooned organ. Previous studies have associated regional expansion of extracellular matrix (ECM) space with tissue morphogenesis during development. We have developed morphoHeart, a 3D tissue segmentation and morphometry software with a user-friendly graphical interface (GUI) that delivers the first integrated 3D visualisation and multiparametric analysis of both heart and ECM morphology in live embryos.
View Article and Find Full Text PDFSuperior vena cava obstruction following pericardial effusion absorption in the presence of a pericardial teratoma: a case report.
J Cardiothorac Surg
January 2025
Department of Cardiac Surgery, Children's Hospital Affiliated Shandong University Jinan Children's Hospital, No. 23976, Jingshi Road, Huaiyin District, Jinan City, Shandong Province, China.
Intrapericardial teratoma is a rare tumor that usually presents in neonates or during infancy because of the associated high degree of pericardial effusion, cardiac compression and severe respiratory distress. In this paper, we report a rare case of intrapericardial teratoma that was incidentally discovered in an infant with superior vena cava obstruction following pericardial effusion absorption. Echocardiography and thoracic computed tomography angiography revealed that the intrapericardial mass obviously suppressed the superior vena cava.
View Article and Find Full Text PDFUse of AI in Cardiac CT and MRI: A Scientific Statement from the ESCR, EuSoMII, NASCI, SCCT, SCMR, SIIM, and RSNA.
Radiology
January 2025
From the Department of Radiology, University of Washington, UW Medical Center-Montlake, Seattle, Wash (D.M.); Department of Radiology, OncoRad/Tumor Imaging Metrics Core (TIMC), University of Washington, Seattle, Wash (D.M.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (M.v.A.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (M.H.); Department of Radiology, Mayo Clinic, Rochester, Minn (T.L., E.E.W.); Departments of Cardiology and Radiology, Royal Brompton Hospital, London, United Kingdom (E.D.N.); School of Biomedical Engineering and Imaging Sciences, King's College, London, United Kingdom (E.D.N.); Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Ill (B.D.A.); Department of Radiology, University of Cagliari, Cagliari, Italy (L.S.); Department of Radiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1 Postbus 30 001, 9700 RB Groningen, the Netherlands (R.V.); Department of Medical Imaging, University Medical Imaging Toronto, University of Toronto, Toronto, Ontario, Canada (K.H.); and Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada (K.H.).
Artificial intelligence (AI) offers promising solutions for many steps of the cardiac imaging workflow, from patient and test selection through image acquisition, reconstruction, and interpretation, extending to prognostication and reporting. Despite the development of many cardiac imaging AI algorithms, AI tools are at various stages of development and face challenges for clinical implementation. This scientific statement, endorsed by several societies in the field, provides an overview of the current landscape and challenges of AI applications in cardiac CT and MRI.
View Article and Find Full Text PDFLesion Formation in Cardiac Pulsed-Field Ablation: Acute to Chronic Cellular Level Changes.
Pacing Clin Electrophysiol
January 2025
Boston Scientific, Corporation: Electrophysiology Research & Development, Arden Hills, Minnesota, USA.
As pulsed-field ablation (PFA) emerges as a promising therapy for atrial arrhythmias, an understanding of the cellular injury to cardiac tissue is critical to evaluating and interpreting results for each PFA system. This review aims to detail the mechanism of cell death for PFA, compare the cell death mechanism to thermal ablation modalities, clarify common histology markers, detail the progression of PFA lesions from the acute, to subacute, to chronic maturation states, and discuss clinical indicators of PFA lesions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!